AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24134409 — intervention group
Group type: EXPERIMENTAL
Intervention: WHO growth standards
Number of subjects: 78
Study 24134409 — intervention group
Group type: COMPARATOR
Intervention: NCHS growth references
Number of subjects: 78
Study 23945723 — intervention group
Group type: EXPERIMENTAL
Intervention: PE-formula
Number of subjects: 18
Study 23945723 — intervention group
Group type: COMPARATOR
Intervention: S-formula
Number of subjects: 18
Study 20462568 — intervention group
Group type: EXPERIMENTAL
Intervention: CP+VF+CR
Number of subjects: 68
Study 20462568 — intervention group
Group type: COMPARATOR
Intervention: EXP
Number of subjects: 68
Study 20462568 — intervention group
Group type: COMPARATOR
Intervention: CP+VF
Number of subjects: 68
Study 18249478 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-alpha as an adjuvant of HBV vaccine
Number of subjects: 0
Study 18249478 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN-alpha
Number of subjects: 0
Study 18249478 — intervention group
Group type: COMPARATOR
Intervention: Control (HBV vaccine without IFN-alpha)
Number of subjects: 0
Study 16754246 — intervention group
Group type: EXPERIMENTAL
Intervention: Semantic word lists (e.g., bed, rest, wake)
Number of subjects: 3
Study 16754246 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonological word lists (e.g., pole, bowl, hole)
Number of subjects: 3
Study 12796026 — intervention group
Group type: COMPARATOR
Intervention: CHOP-21
Number of subjects: 959
Study 12796026 — intervention group
Group type: COMPARATOR
Intervention: CHOP-14
Number of subjects: 959
Study 12796026 — intervention group
Group type: COMPARATOR
Intervention: CHOEP-21
Number of subjects: 959
Study 12796026 — intervention group
Group type: COMPARATOR
Intervention: CHOEP-14
Number of subjects: 959
Study 12796026 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOP-14 with rhG-CSF
Number of subjects: 959
Study 12796026 — intervention group
Group type: EXPERIMENTAL
Intervention: CHOEP-21 and CHOEP-14
Number of subjects: 959
Study 10926073 — intervention group
Group type: COMPARATOR
Intervention: Sham block (Group I)
Number of subjects: 30
Study 10926073 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritonsillar block with bupivacaine 0.25% before tonsillectomy (Group II)
Number of subjects: 30
Study 10926073 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritonsillar block with bupivacaine 0.25% immediately after surgery (Group III)
Number of subjects: 30
Study 8929202 — intervention group
Group type: EXPERIMENTAL
Intervention: Water Immersion (WI)
Number of subjects: 7
Study 8929202 — intervention group
Group type: EXPERIMENTAL
Intervention: Head-Down Tilt (HDT)
Number of subjects: 7
Study 8929202 — intervention group
Group type: COMPARATOR
Intervention: Ambulatory Control (AC)
Number of subjects: 7
Study 1430354 — intervention group
Group type: EXPERIMENTAL
Intervention: Stokogard
Number of subjects: 20
Study 1430354 — intervention group
Group type: EXPERIMENTAL
Intervention: Hollister Moisture Barrier
Number of subjects: 20
Study 1430354 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydropel
Number of subjects: 20
Study 1430354 — intervention group
Group type: EXPERIMENTAL
Intervention: Ivy Shield
Number of subjects: 20
Study 1430354 — intervention group
Group type: EXPERIMENTAL
Intervention: Shield Skin
Number of subjects: 20
Study 1430354 — intervention group
Group type: EXPERIMENTAL
Intervention: Dermofilm
Number of subjects: 20
Study 1430354 — intervention group
Group type: EXPERIMENTAL
Intervention: Uniderm
Number of subjects: 20
Study 1430354 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated area)
Number of subjects: 20
Study 6941637 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to a cold room (‐10 degrees C) and inhalation of very cold air (‐35 degrees C)
Number of subjects: 0
Study 6941637 — intervention group
Group type: COMPARATOR
Intervention: Exposure to 10 and 0 degrees C environmental temperature and inhalation of moderately cold air (‐10 degrees C)
Number of subjects: 0
Study 31178009 — intervention group
Group type: EXPERIMENTAL
Intervention: Developing Relationships that Include Values of Eating and Exercise (DRIVE) intervention
Number of subjects: 16
Study 31178009 — intervention group
Group type: COMPARATOR
Intervention: Health education
Number of subjects: 16
Study 28032303 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HCT) administration
Number of subjects: 0
Study 28032303 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26338885 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cholecalciferol supplements of 10 μg/d for 3 mo
Number of subjects: 24
Study 26338885 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cholecalciferol supplements of 25 μg/d for 3 mo
Number of subjects: 24
Study 26338885 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cholecalciferol supplements of 50 μg/d for 3 mo
Number of subjects: 24
Study 26338885 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 24
Study 23648394 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight management program 1
Number of subjects: 550
Study 23648394 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight management program 2
Number of subjects: 550
Study 23648394 — intervention group
Group type: COMPARATOR
Intervention: Non-randomized observational control group
Number of subjects: 550
Study 21169285 — intervention group
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography (PET)
Number of subjects: 54
Study 21169285 — intervention group
Group type: EXPERIMENTAL
Intervention: Volume Doubling Time (VDT)
Number of subjects: 54
Study 21169285 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of PET and VDT
Number of subjects: 54
Study 19585872 — intervention group
Group type: EXPERIMENTAL
Intervention: Ecopass traffic restriction fee enforcement
Number of subjects: 0
Study 17518162 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention (one 60-90 minute session delivered by a nurse and psychologist)
Number of subjects: 22
Study 17518162 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 22
Study 16513899 — intervention group
Group type: EXPERIMENTAL
Intervention: Academic detailing intervention (multicomponent physician-directed education using American Cancer Society guidelines)
Number of subjects: 168
Study 16513899 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 168
Study 14597945 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon-expandable Palmaz stents
Number of subjects: 21
Study 14597945 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-expandable nitinol aortic stents
Number of subjects: 21
Study 10474084 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood transfusion (average 4.49+/‐3.3 U/patient, range 1‐14)
Number of subjects: 182
Study 10474084 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion-associated hepatitis due to HCV
Number of subjects: 182
Study 10474084 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfusion-associated hepatitis due to HBV
Number of subjects: 182
Study 10474084 — intervention group
Group type: EXPERIMENTAL
Intervention: Coinfection of HBV and HCV
Number of subjects: 182
Study 10474084 — intervention group
Group type: EXPERIMENTAL
Intervention: TAH due to HBV
Number of subjects: 182
Study 10474084 — intervention group
Group type: EXPERIMENTAL
Intervention: TAH due to HCV
Number of subjects: 182
Study 8953681 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin 1 g b.i.d. for 6 days
Number of subjects: 342
Study 8953681 — intervention group
Group type: COMPARATOR
Intervention: Penicillin V 1 MU t.i.d. for 10 days
Number of subjects: 342
Study 1789034 — intervention group
Group type: EXPERIMENTAL
Intervention: Lyophilized acellular staphylococcal vaccine
Number of subjects: 0
Study 1789034 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% sodium chloride solution)
Number of subjects: 0
Study 7019230 — intervention group
Group type: EXPERIMENTAL
Intervention: salmon calcitonin (100 Medical Research Council Units)
Number of subjects: 16
Study 29995274 — intervention group
Group type: EXPERIMENTAL
Intervention: Active transcranial direct current stimulation (tDCS) over the medial frontal cortex (MFC)
Number of subjects: 16
Study 29995274 — intervention group
Group type: COMPARATOR
Intervention: Sham transcranial direct current stimulation (tDCS)
Number of subjects: 16
Study 28936901 — intervention group
Group type: EXPERIMENTAL
Intervention: Inductive learning approach
Number of subjects: 84
Study 28936901 — intervention group
Group type: EXPERIMENTAL
Intervention: Deductive learning approach
Number of subjects: 84
Study 26220050 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Training plus Phototherapy (ET-PHOTO)
Number of subjects: 64
Study 26220050 — intervention group
Group type: COMPARATOR
Intervention: Exercise Training plus SHAM (ET-SHAM)
Number of subjects: 64
Study 23864540 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral thiamine hydrochloride 100 mg for 5 days
Number of subjects: 16
Study 20939638 — intervention group
Group type: EXPERIMENTAL
Intervention: Appearance-focused intervention
Number of subjects: 379
Study 20939638 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 379
Study 18244953 — intervention group
Group type: EXPERIMENTAL
Intervention: TPI ASM8 (1,500 microg, inhaled by nebulizer, once daily for 4 days)
Number of subjects: 17
Study 15697326 — intervention group
Group type: EXPERIMENTAL
Intervention: Zolmitriptan 5mg nasal spray
Number of subjects: 2122
Study 15697326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2122
Study 12591752 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral valve (MV) repair surgery
Number of subjects: 26
Study 10932687 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.5 mg.kg‐1 propofol
Number of subjects: 80
Study 10932687 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.5 mg.kg‐1 propofol
Number of subjects: 80
Study 10932687 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dose propofol (1.5 mg.kg‐1)
Number of subjects: 80
Study 10932687 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose propofol (2.5 mg.kg‐1)
Number of subjects: 80
Study 8671971 — intervention group
Group type: EXPERIMENTAL
Intervention: CU dialyser
Number of subjects: 8
Study 8671971 — intervention group
Group type: EXPERIMENTAL
Intervention: CTA dialyser
Number of subjects: 8
Study 8671971 — intervention group
Group type: EXPERIMENTAL
Intervention: PS dialyser
Number of subjects: 8
Study 8671971 — intervention group
Group type: EXPERIMENTAL
Intervention: CTA, CU, and PS dialysers
Number of subjects: 8
Study 1768565 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol (1 x 100 mg day‐1) for 6 weeks
Number of subjects: 16
Study 1768565 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (1 x 100 mg day‐1) for 6 weeks
Number of subjects: 16
Study 1768565 — intervention group
Group type: COMPARATOR
Intervention: Atenolol and Captopril
Number of subjects: 16
Study 6817776 — intervention group
Group type: EXPERIMENTAL
Intervention: Disodium cromoglycate (DSCG) 20 mg q.d.s.
Number of subjects: 0
Study 6817776 — intervention group
Group type: COMPARATOR
Intervention: Ketotifen 1 mg b.d.
Number of subjects: 0
Study 6817776 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31927027 — intervention group
Group type: EXPERIMENTAL
Intervention: TCu380A IUD
Number of subjects: 140
Study 31927027 — intervention group
Group type: COMPARATOR
Intervention: Levonorgestrel (LNG) 52 mg IUS
Number of subjects: 140
Study 31796495 — intervention group
Group type: EXPERIMENTAL
Intervention: PEEK cranioplasty
Number of subjects: 140
Study 31796495 — intervention group
Group type: COMPARATOR
Intervention: Titanium cranioplasty
Number of subjects: 140
Study 28439700 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim
Number of subjects: 42
Study 28439700 — intervention group
Group type: COMPARATOR
Intervention: Pegfilgrastim
Number of subjects: 42
Study 26369653 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 20
Study 26369653 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 20
Study 23904883 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomiphene Citrate (CC) + Metformin
Number of subjects: 42
Study 23904883 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene Citrate (CC) alone
Number of subjects: 42
Study 21338805 — intervention group
Group type: EXPERIMENTAL
Intervention: High-milk, early-weaned: fed 12 L/d of milk and weaned at 47 d of age
Number of subjects: 9
Study 21338805 — intervention group
Group type: COMPARATOR
Intervention: Low-milk, early-weaned: fed 6 L/d of milk and weaned at 47 d of age
Number of subjects: 9
Study 21338805 — intervention group
Group type: EXPERIMENTAL
Intervention: High-milk, later-weaned: fed 12 L/d of milk and weaned at 89 d of age
Number of subjects: 9
Study 19270249 — intervention group
Group type: EXPERIMENTAL
Intervention: Scales of Psychological Capacities (SPC) applied to borderline patients
Number of subjects: 105
Study 19270249 — intervention group
Group type: EXPERIMENTAL
Intervention: Scales of Psychological Capacities (SPC) applied to depressed women
Number of subjects: 105
Study 19270249 — intervention group
Group type: COMPARATOR
Intervention: Scales of Psychological Capacities (SPC) applied to healthy controls
Number of subjects: 105
Study 17418321 — intervention group
Group type: EXPERIMENTAL
Intervention: Hygiene promotion (medicine provided and hygiene promotion activity)
Number of subjects: 276
Study 17418321 — intervention group
Group type: COMPARATOR
Intervention: Treatment (medicine provided, no hygiene promotion activity)
Number of subjects: 276
Study 17418321 — intervention group
Group type: COMPARATOR
Intervention: Seasonality (no medicine, no hygiene promotion activity)
Number of subjects: 276
Study 15478381 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast, 10 mg daily
Number of subjects: 14
Study 15478381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 11402366 — intervention group
Group type: EXPERIMENTAL
Intervention: SCIM
Number of subjects: 22
Study 11402366 — intervention group
Group type: COMPARATOR
Intervention: FIM
Number of subjects: 22
Study 9430868 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-cuff Tenckhoff catheter
Number of subjects: 60
Study 9430868 — intervention group
Group type: COMPARATOR
Intervention: Double-cuff Tenckhoff catheter
Number of subjects: 60
Study 8500867 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg indomethacin for 5 days
Number of subjects: 35
Study 8500867 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 5 days
Number of subjects: 35
Study 3551668 — intervention group
Group type: EXPERIMENTAL
Intervention: EFA supplementation
Number of subjects: 27
Study 3551668 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 30789808 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol 600 mg daily for 12 weeks
Number of subjects: 50
Study 30789808 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 30513768 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypocaloric very low carbohydrate (VLC) diet (4⁻10% of total energy intake)
Number of subjects: 36
Study 30513768 — intervention group
Group type: COMPARATOR
Intervention: Hypocaloric low fat (LF) diet (<30% of total energy intake)
Number of subjects: 36
Study 27091274 — intervention group
Group type: EXPERIMENTAL
Intervention: Heel suspension device boot
Number of subjects: 183
Study 27091274 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control)
Number of subjects: 183
Study 24689967 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil capsules (4 g daily for 6 weeks)
Number of subjects: 21
Study 24689967 — intervention group
Group type: COMPARATOR
Intervention: Placebo (identical-looking capsules for 6 weeks)
Number of subjects: 21
Study 22945713 — intervention group
Group type: COMPARATOR
Intervention: Variolink II (Var II) resin cement
Number of subjects: 40
Study 22945713 — intervention group
Group type: EXPERIMENTAL
Intervention: RelyX Unicem (RX)
Number of subjects: 40
Study 22945713 — intervention group
Group type: EXPERIMENTAL
Intervention: Maxcem (Mc)
Number of subjects: 40
Study 22945713 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilink Sprint (MS)
Number of subjects: 40
Study 20156150 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine (8-32 mg for IR tablets; 8-24 mg for ER capsules)
Number of subjects: 0
Study 20156150 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine co-administered with ketoconazole
Number of subjects: 0
Study 20156150 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine co-administered with paroxetine
Number of subjects: 0
Study 20156150 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine in patients with moderate renal impairment
Number of subjects: 0
Study 20156150 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine in patients with severe renal impairment
Number of subjects: 0
Study 20156150 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine in patients with moderate hepatic impairment
Number of subjects: 0
Study 18294323 — intervention group
Group type: EXPERIMENTAL
Intervention: Ifosfamide 9 g m(‐2) given by a 3 h infusion
Number of subjects: 17
Study 18294323 — intervention group
Group type: EXPERIMENTAL
Intervention: Ifosfamide 9 g m(‐2) given by a 72 h infusion
Number of subjects: 17
Study 16187510 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with PFPS after sitting for 20 minutes
Number of subjects: 28
Study 16187510 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants with PFPS
Number of subjects: 28
Study 16187510 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 28
Study 14516798 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical corticosteroids (Group 3)
Number of subjects: 32
Study 14516798 — intervention group
Group type: COMPARATOR
Intervention: Topical artificial tear substitute (ATS) (Group 1)
Number of subjects: 32
Study 14516798 — intervention group
Group type: COMPARATOR
Intervention: ATS plus nonsteroidal anti-inflammatory drops (NSAID) (Group 2)
Number of subjects: 32
Study 11368654 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 g of OSA-substituted starch
Number of subjects: 30
Study 11368654 — intervention group
Group type: COMPARATOR
Intervention: 25 g of glucose
Number of subjects: 30
Study 9196520 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjustable mandibular positioner (AMP)
Number of subjects: 20
Study 9196520 — intervention group
Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (nCPAP)
Number of subjects: 20
Study 1494114 — intervention group
Group type: EXPERIMENTAL
Intervention: XR-Ionomer
Number of subjects: 0
Study 1494114 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuji Lining LC
Number of subjects: 0
Study 1494114 — intervention group
Group type: COMPARATOR
Intervention: Chemically cured glass ionomer cement
Number of subjects: 0
Study 3516077 — intervention group
Group type: EXPERIMENTAL
Intervention: Indomethacin (0.2 mg/kg)
Number of subjects: 50
Study 3516077 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 50
Study 31504699 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-Grain (WG) diet
Number of subjects: 46
Study 31504699 — intervention group
Group type: COMPARATOR
Intervention: Refined-Wheat (RW) diet
Number of subjects: 46
Study 25416463 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal smoking during pregnancy
Number of subjects: 496
Study 26537306 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (three one-hour sessions per week for 12 weeks)
Number of subjects: 60
Study 26537306 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study 23581590 — intervention group
Group type: EXPERIMENTAL
Intervention: Subarachnoid clot burden
Number of subjects: 413
Study 23581590 — intervention group
Group type: EXPERIMENTAL
Intervention: Subdural hematoma
Number of subjects: 413
Study 23581590 — intervention group
Group type: EXPERIMENTAL
Intervention: Subarachnoid clot burden cutoff
Number of subjects: 413
Study 22139778 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based simulation followed by manikin simulation (Group 1)
Number of subjects: 40
Study 22139778 — intervention group
Group type: COMPARATOR
Intervention: Manikin simulation followed by web-based simulation (Group 2)
Number of subjects: 40
Study 22139778 — intervention group
Group type: EXPERIMENTAL
Intervention: Both simulations
Number of subjects: 40
Study 22139778 — intervention group
Group type: EXPERIMENTAL
Intervention: Manikin simulation
Number of subjects: 40
Study 19699885 — intervention group
Group type: EXPERIMENTAL
Intervention: CorCap plus RMA
Number of subjects: 30
Study 19699885 — intervention group
Group type: COMPARATOR
Intervention: RMA alone
Number of subjects: 30
Study 16139331 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 160 mg/day
Number of subjects: 267
Study 16139331 — intervention group
Group type: EXPERIMENTAL
Intervention: Warfarin (INR 2.8‐4.2)
Number of subjects: 267
Study 16139331 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin 75 mg/day plus Warfarin (INR 2.0‐2.5)
Number of subjects: 267
Study 16139331 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups (Aspirin, Warfarin, or both)
Number of subjects: 267
Study 15632886 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct stenting (DS)
Number of subjects: 128
Study 15632886 — intervention group
Group type: COMPARATOR
Intervention: Conventional stenting (CS)
Number of subjects: 128
Study 11873095 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 5 mg
Number of subjects: 502
Study 11873095 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 502
Study 11873095 — intervention group
Group type: COMPARATOR
Intervention: Pravastatin 20 mg
Number of subjects: 502
Study 11873095 — intervention group
Group type: COMPARATOR
Intervention: Simvastatin 20 mg
Number of subjects: 502
Study 9779038 — intervention group
Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccination
Number of subjects: 0
Study 8141163 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mmol/d Na intake
Number of subjects: 24
Study 8141163 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mmol/d Na intake
Number of subjects: 24
Study 8141163 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mmol/d Na intake
Number of subjects: 24
Study 3207127 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral phenobarbital (90 mg daily)
Number of subjects: 52
Study 3207127 — intervention group
Group type: COMPARATOR
Intervention: No therapy (control group)
Number of subjects: 52